Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

SCLC,Extensive Stage × niraparib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 23 Prostatic Neoplasms 10 Breast Neoplasms 10 Fallopian Tube Neoplasms 9 Neoplasms 7 Neoplasm Metastasis 7 Pancreatic Neoplasms 6 Endometrial Neoplasms 5 Glioblastoma 4 Triple Negative Breast Neoplasms 3 Lung Neoplasms 3 Glioma 3 Small Cell Lung Carcinoma 2 Recurrence 2 Prostatic Neoplasms, Castration-Resistant 2 Head and Neck Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Advanced Solid Tumor 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Unilateral Breast Neoplasms 1 Sarcoma 1 SCLC,Extensive Stage 1 Rectal Neoplasms 1 Prostate Carcinoma Metastatic to the Bone 1 Prostate Adenocarcinoma 1

Interventions

Etoposide 2 pembrolizumab 1 olaparib 1 niraparib 1 atezolizumab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05718323 2026-02-06

RAISE

ETOP IBCSG Partners Foundation

Phase 2 Recruiting

SCLC,Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡